Targeting the intracellular signaling "STOP" and "GO" pathways for the treatment of alcohol use disorders

被引:26
|
作者
Ron, Dorit [1 ]
Berger, Anthony [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
关键词
Alcohol; Addiction; Signaling; Translation; Medication Development; Fyn; mTOR; BDNF; GDNF; LONG-TERM POTENTIATION; NR2B-CONTAINING NMDA-RECEPTORS; CONDITIONED-PLACE PREFERENCE; ACTIVITY-DEPENDENT SECRETION; TYROSINE-PHOSPHATASE ALPHA; P75 NEUROTROPHIN RECEPTOR; DOPAMINE D-3 RECEPTOR; ANTI-ADDICTION DRUG; SYNAPTIC PLASTICITY; DORSOMEDIAL STRIATUM;
D O I
10.1007/s00213-018-4882-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In recent years, research has identified the molecular and neural substrates underlying the transition of moderate "social" consumption of alcohol to the characteristic alcohol use disorder (AUD) phenotypes including excessive and compulsive alcohol use which we define in the review as the GO signaling pathways. In addition, growing evidence points to the existence of molecular mechanisms that keep alcohol consumption in check and that confer resilience for the development of AUD which we define herein as the STOP signaling pathways. In this review, we focus on examples of the GO and the STOP intracellular signaling pathways and discuss our current knowledge of how manipulations of these pathways may be used for the treatment of AUD.
引用
收藏
页码:1727 / 1743
页数:17
相关论文
共 50 条
  • [31] Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
    Koury, Jeffrey
    Zhong, Li
    Hao, Jijun
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [32] Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer
    Jamal Hallajzadeh
    Parisa Maleki Dana
    Moein Mobini
    Zatollah Asemi
    Mohammad Ali Mansournia
    Mehran Sharifi
    Bahman Yousefi
    Medical Oncology, 2020, 37
  • [33] Anticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders
    Hammond, Christopher J.
    Niciu, Mark J.
    Drew, Shannon
    Arias, Albert J.
    CNS DRUGS, 2015, 29 (04) : 293 - 311
  • [34] Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer
    Hallajzadeh, Jamal
    Dana, Parisa Maleki
    Mobini, Moein
    Asemi, Zatollah
    Mansournia, Mohammad Ali
    Sharifi, Mehran
    Yousefi, Bahman
    MEDICAL ONCOLOGY, 2020, 37 (06)
  • [35] Anticytokine Agents Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
    Ridker, Paul M.
    CIRCULATION RESEARCH, 2019, 124 (03) : 437 - 450
  • [36] Anticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders
    Christopher J. Hammond
    Mark J. Niciu
    Shannon Drew
    Albert J. Arias
    CNS Drugs, 2015, 29 : 293 - 311
  • [37] New Pharmacotherapy for Airway Mucus Hypersecretion in Asthma and COPD: Targeting Intracellular Signaling Pathways
    Lai, HonYee
    Rogers, Duncan F.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2010, 23 (04) : 219 - 231
  • [38] HEALTH LITERACY IN THE TREATMENT OF ALCOHOL USE DISORDERS
    Skewes, M. C.
    Dermen, K. H.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (06) : 127A - 127A
  • [39] Oxytocin for the treatment of drug and alcohol use disorders
    Lee, Mary R.
    Weerts, Elise M.
    BEHAVIOURAL PHARMACOLOGY, 2016, 27 (08): : 640 - 648
  • [40] Role of exercise in the treatment of alcohol use disorders
    Manthou, Eirini
    Georgakouli, Kalliopi
    Fatouros, Ioannis G.
    Gianoulakis, Christina
    Theodorakis, Yannis
    Jamurtas, Athanasios Z.
    BIOMEDICAL REPORTS, 2016, 4 (05) : 535 - 545